PFM Health Sciences’s Qualcomm QCOM Stock Holding History

PFM Health Sciences’s Portfolio QCOM Stock Details QCOM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-447,578	Closed	-$33.3M	–	98
2014 Q4	$33.3M	Buy	+447,578	New	+$32.8M	0.78%	45

Other funds holding QCOM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

PFM Health Sciences's QCOM Position: Q1 2015 in Review

PFM Health Sciences sold out of Qualcomm (QCOM) in Q1 2015, closing a stake of 447,578 shares — an estimated $33.3M sold.

PFM Health Sciences first reported a position in QCOM in Q4 2014 and held it in 1 quarter. The position peaked at $33.3M in Q4 2014. 1,554 funds tracked by Wall St. Rank hold QCOM as of Q1 2015.

PFM Health Sciences reported no remaining Qualcomm position as of Q1 2015 after selling out during the quarter.
PFM Health Sciences sold 447,578 Qualcomm shares in Q1 2015, an estimated $33.3M.
PFM Health Sciences first reported a position in Qualcomm in Q4 2014 and held it in 1 quarter.
PFM Health Sciences's Qualcomm position peaked at $33.3M in Q4 2014.
1,554 funds tracked by Wall St. Rank held Qualcomm as of Q1 2015.

Based on PFM Health Sciences's 13F filing for Q1 2015, filed 15 May 2015.